Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia

Overview of attention for article published in Journal for Immunotherapy of Cancer, May 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 13 X posts from 9 X users, with an upper bound of 29,899 followers.

#JITC Research: Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia https://t.co/guRgFTAN5s https://t.co/jZZC4SQKcq

#JITC Research: Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia https://t.co/guRgFTAN5s https://t.co/J3ELNentjR

RT @sitcancer: #JITC Research: Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.